Literature DB >> 18418295

Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004.

Julia A Schillinger1, Christy M McKinney, Renu Garg, R Charon Gwynn, Kellee White, Francis Lee, Susan Blank, Lorna Thorpe, Thomas Frieden.   

Abstract

BACKGROUND: Herpes simplex virus type 2 (HSV-2) infection is associated with substantial morbidity and increased risk for human immunodeficiency virus acquisition. We describe HSV-2 seroprevalence in adult New Yorkers, and examine the relationship between select characteristics, infection, and diagnosis.
METHODS: HSV-2 seroprevalence and risk factors were measured using the 2004 New York City Health and Nutrition Examination Survey, a population-based cross-sectional survey of adults. HSV-2 seroprevalence and corresponding 95% confidence intervals were computed for select characteristics. Associations between proposed risk factors and HSV-2 infection and diagnosis were estimated using unadjusted and adjusted odds ratios.
RESULTS: Nearly 28% of adults were infected with HSV-2; 88.4% of HSV-2 positive persons were undiagnosed. Black women had the highest seroprevalence (59.7%) of any sex or race/ethnicity group. Women, non-Hispanic blacks, and Hispanics (vs. non-Hispanic whites), and men who have sex with men were at greater odds of HSV-2 infection. Among HSV-2 infected individuals, non-Hispanic blacks (vs. non-Hispanic whites), uncircumcised men, and those with no routine place of care were less likely to be diagnosed.
CONCLUSIONS: HSV-2 is highly prevalent and largely undiagnosed in New York City; seroprevalence varies by subgroup. Targeted HSV-2 screening, counseling and treatment may help reduce transmission of HSV-2 and human immunodeficiency virus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418295     DOI: 10.1097/OLQ.0b013e3181666fb1

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  14 in total

1.  Racial/ethnic disparities in undiagnosed infection with herpes simplex virus type 2.

Authors:  Enrique R Pouget; Trace S Kershaw; Kim M Blankenship; Jeannette R Ickovics; Linda M Niccolai
Journal:  Sex Transm Dis       Date:  2010-09       Impact factor: 2.830

2.  Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas.

Authors:  H Hagan; S M Jenness; T Wendel; C R Murrill; A Neaigus; C Gelpi-Acosta
Journal:  Int J STD AIDS       Date:  2010-08       Impact factor: 1.359

3.  High Rates of Herpes Simplex Virus Type 2 Infection in Homeless Women: Informing Public Health Strategies.

Authors:  J Daniel Kelly; Jennifer Cohen; Barbara Grimes; Susan S Philip; Sheri D Weiser; Elise D Riley
Journal:  J Womens Health (Larchmt)       Date:  2016-05-31       Impact factor: 2.681

4.  Parallel declines in HIV and hepatitis C virus prevalence, but not in herpes simplex virus type 2 infection: A 10-year, serial cross-sectional study in an inner-city emergency department.

Authors:  Eshan U Patel; Oliver Laeyendecker; Yu-Hsiang Hsieh; Richard E Rothman; Gabor D Kelen; Thomas C Quinn
Journal:  J Clin Virol       Date:  2016-05-10       Impact factor: 3.168

5.  Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.

Authors:  Christopher D Conrady; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

Review 6.  Group sex events amongst non-gay drug users: an understudied risk environment.

Authors:  Samuel R Friedman; Pedro Mateu-Gelabert; Milagros Sandoval
Journal:  Int J Drug Policy       Date:  2010-08-25

7.  Sexual HIV/HSV-2 risk among drug users in New York City: an HIV testing and counseling intervention.

Authors:  Marlene Pantin; Noelle R Leonard; Holly Hagan
Journal:  Subst Use Misuse       Date:  2013-03-25       Impact factor: 2.164

8.  Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico.

Authors:  Cynthia M Pérez; Edmir Marrero; Marytere Meléndez; Sandra Adrovet; Héctor Colón; Ana P Ortiz; Marievelisse Soto-Salgado; Carmen Albizu; Esther A Torres; Erick Suárez
Journal:  BMC Infect Dis       Date:  2010-03-23       Impact factor: 3.090

9.  Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection.

Authors:  Joseph G Skeate; Tania B Porras; Andrew W Woodham; Julie K Jang; Julia R Taylor; Heike E Brand; Thomas J Kelly; Jae U Jung; Diane M Da Silva; Weiming Yuan; W Martin Kast
Journal:  J Gen Virol       Date:  2015-11-10       Impact factor: 3.891

10.  Epidemiological impact of a genital herpes type 2 vaccine for young females.

Authors:  Yijun Lou; Redouane Qesmi; Qian Wang; Marc Steben; Jianhong Wu; Jane M Heffernan
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.